Latest News

Genomics plc appointed as Analysis Partner for Genomics England GENE Consortium

17th October 2016

All News | Spinouts & Startups

Genomics plc, a 2014 spinout company that is developing an integrated platform to uncover the relationships between genetic variation and human disease, has been appointed as Analysis Partner for the Genomics England Genomics Expert Network for Enterprises (GENE) Consortium.

Oxford spinout develops smart glasses giving legally blind the ability to read and navigate

27th July 2016

All News | Spinouts & Startups

University spinout OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

Oxford spinout’s diagnostic tests take just weeks to develop

25th July 2016

All News | Spinouts & Startups

A technology co-developed at the Universities of Oxford and Sao Paulo State University in Brazil will be commercialised by spinout OID (Oxford Impedance Diagnostics), offering the potential for ultrasensitive fast diagnostic tests for a range of diseases.

Oxford Technology Showcase: Big Healthcare Challenges in Chronic Disease

7th July 2016

All News | Spinouts & Startups | Technology News

The fourth annual Oxford Technology Showcase was held on Wednesday 6th July at Oxford’s Saïd Business School. The event brought together experts and innovators from Oxford University, the Oxford University Hospital Trust and the Oxfordshire region. Over 300 investors, entrepreneurs, healthcare companies, researchers and clinicians attended.

Oxford Startup TalkAbout launches Tour Guide App at Bodleian

7th July 2016

All News | Spinouts & Startups | Technology News

In conjunction with Shakespeare’s Dead at the Bodleian’s Weston Library: TalkAbout Guides App available 1 July – 18 September 2016, free download for iOs and Android.

Oxford spinout OMass Technologies provides native mass spectrometry to pharma and biotech

14th June 2016

All News | Spinouts & Startups

Oxford spinout raises £10m for precision system to treat disease

10th May 2016

All News | Spinouts & Startups

Oxford spinout EvOx Therapeutics will harness the body’s own precision communications system to deliver drugs to specific parts of the body, with the aim of treating conditions which are currently untreatable including those affecting the brain, as well as autoimmune diseases and cancers.

Universal flu vaccine under development by Oxford spinout Vaccitech

10th May 2016

All News | Spinouts & Startups

Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials. Large investment of £10m from Oxford Science Enterprises. Further programs include vaccines to boost cancer immunotherapies.

Record £16.9m for Oxford spinout designing stem cell drugs to treat age-related disease

10th May 2016

All News | Spinouts & Startups

One of the most ambitious Oxford spinouts to date is on route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions

Oxford Nanoimaging to provide desktop super-resolution microscopes

10th May 2016

All News | Spinouts & Startups

Oxford Nanoimaging -- a University of Oxford spinout -- will commence sales of an elegant desktop optical microscope capable of zooming in on objects as tiny as structures inside living cells. This super-resolution microscope will allow scientists to watch how individual molecules perform chemical reactions in real-time.

News

Ready to get in touch?